Medical supplies contracts

4,375 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Lapatinib, ATC L01EH01 for the period 01.05.26-30.04.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 184297-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Nintedanib (OFEV and generics), ATC L01EX09 for the period 01.05.26-30.04.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 184900-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Dydrogesterone + Estrogen, ATC G03FB08, for the period 01.05.26 - 30.04.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 180143-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Enalapril (excluding 2, 5 mg + 5 mg), ATC C09AA02 for the period 01.05.26 - 30.04.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 178549-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Estradiol (excluding DaFo UTA/TAB), ATC G03CA03 for the period 01.05.26-30.04.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 183676-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Nintedanib (VARGATEF and generics), ATC L01EX09 for the period 01.05.26-30.04.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 184994-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance chlorthalidone, ATC C03BA04, for the period 01.05.26 – 30.04.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 182116-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Clindamycin (excluding DaFo VSU), ATC G01AA10 for the period 01.05.26 - 30.04.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 177876-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Ciclopirox, ATC D01AE14, for the period 01.05.26 - 30.04.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 180782-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Diltiazem, ATC C08DB01, for the period 01.05.26 - 30.04.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 179241-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance estradiol (excluding DaFo GEL), ATC G03CA03, for the period 01.05.26 – 30.04.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 181797-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance estradiol (excluding DaFo SPT), ATC G03CA03, for the period 01.05.26 – 30.04.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 183394-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Pimecrolimus, ATC D11AH02 for the period 01.05.26 - 30.04.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 179102-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Dalbavancin, ATC J01XA04 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 264337-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Mesalazine (excluding Dafo RSU + KLI), ATC A07EC02 for the period 01.06.26 - 31.05.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 265020-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Clobazam (excluding Dafo TAB), ATC N05BA09 for the period 01.06.2026 - 31.05.2028 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 265426-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Clobazam (excluding Dafo SUE), ATC N05BA09 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 262578-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Gentamicin, ATC S01AA11 for the period 01.06.2026 - 31.05.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 263899-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Ganirelix, ATC H01CC01 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 264661-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Tianeptine, ATC N06AX14 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 263478-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.